T he management of splenic injuries has evolved over the past two decades. In an effort to minimize patient morbidity and preserve splenic function, nonoperative management of stable patients has become the standard of care. [1] [2] [3] [4] Early nonoperative failure rates were relatively high, and a number of investigators sought to identify risk factors for failure of nonoperative management. [5] [6] [7] One particular finding that was associated with a high rate of failure was a contrast blush on initial computed tomography (CT) scan. 8 Splenic angioembolization (EMBO) was first described in 1981 by Sclafani 9 as an effective means of achieving hemostasis of splenic injuries, and it became much more widely used in the late 1990s. Many individual institutional reviews have supported the use of EMBO to increase the success rate of nonoperative management, with failure rates as low as 5 to 7%. 5, 6, 10, 11 The Western Trauma Association (WTA) Multicenter Review reported an EMBO failure rate of 13%. 12 Success rates decreased with increasing grade, but even the grade IV and V injuries had EMBO success rates Ͼ80%. Rhode Island Hospital (RIH) was one of the four contributing institutions, providing data through the year 2002. Our institutional clinical pathway has called for EMBO in the setting of contrast blush on CT scan or ongoing splenic bleeding. However, since our participation in the WTA review, we have perceived a higher rate of EMBO failure than that reported in the literature. Just as Velmahos and colleagues 13 questioned the liberal use of nonoperative management of splenic injuries, we wondered if we had gone too far in employing EMBO as an alternative to operative intervention. The purpose of this study was to review our experience with splenic EMBO and to identify predictors of failure.
PATIENTS AND METHODS
RIH is a 719-bed American College of Surgeons-verified Level I trauma center. It is the only trauma center in Rhode Island and also serves as a referral center for southeastern Massachusetts and eastern Connecticut. A RIH institutional management algorithm for blunt splenic trauma was published in our Trauma Handbook in 1999 (Fig. 1) . A stable patient with a splenic injury by CT scan is taken for EMBO if there is an arterial blush on CT. Additionally, patients without arterial blushes may be considered for EMBO if they show signs of ongoing bleeding attributed to the splenic injury. Embolization techniques (coil vs. particulate embolization and proximal vs. distal arterial embolization) are at the discretion of the attending interventional radiologist.
This study was approved by the Institutional Review Board of RIH. Trauma registry and interventional radiology databases were searched to identify all patients with blunt splenic injuries and those undergoing splenic artery EMBO between January 2000 through June 2004. A detailed chart review was performed for all patients undergoing EMBO. All of the admission CT scans were re-read and graded according to the AAST Spleen Injury Scale 14 by a radiologist (R.L.) blinded to the clinical outcome. He also defined the degree of hemoperitoneum as none, small (perisplenic blood only), moderate (perisplenic plus paracolic blood) and large (blood in the pelvis). 4 All EMBO studies were reviewed by the radiologist for techniques, findings, and results.
Statistical analysis was performed using the SAS System (SAS Institute, Cary, N.C.). Bivariate relationships between predictive factors were assessed using the Fischer's Exact Test in the case of dichotomous variables and Pearson Correlation in the case of continuous variables. The predictive ability of factors was assessed using a multiple logistic regression with stepwise variable selection. Individual variables were sequentially added, or removed, based on significance level (Wald test) and the model re-assessed until only variables whose significance level was below 0.05 were remaining.
RESULTS
During the study period, 221 patients were admitted with blunt splenic injuries. There were 151 (68%) male patients and 70 (32%) female patients with a mean age of 38 (range, 17-93). Fifty-six (25%) patients went directly to the operating room (OR) and underwent splenectomy ( Table 1) . Of the remaining 165, 124 (75%) were managed expectantly and 41 (25%) were taken for EMBO. The overall failure rate of nonoperative management was 14%. The failure rate increased with increasing injury grade for the overall group and for those managed without EMBO ( Table 2 ). Of the patients who underwent EMBO, none of those with grade I or II injuries failed. However, 40% with grade III, 38% with grade IV, and 40% with grade V injuries ultimately required splenectomy. Overall, there was a 27% failure rate of EMBO.
Failure of EMBO as it related to degree of hemoperitoneum is shown in Table 3 . Most patients undergoing EMBO had large hemoperitoneum (56%), but the failure rate was highest among those with moderate hemoperitoneum. If there was no or small hemoperitoneum, only 1 (8%) of 13 patients failed EMBO. This patient had a grade IV splenic injury. On the other hand, 10 (36%) of 28 with moderate or large hemoperitoneum failed. All had grade III, IV, or V injuries. Four of the 41 EMBO patients experienced transient hypotension in the emergency department (ED) and three of these patients ultimately required splenectomy.
Angiography appears to have good predictive value. Embolization was more likely to fail if active extravasation was seen on angiography before embolization (59%), versus 4% if no active extravasation was seen (odds ratio [OR] 32.9; 95% confidence interval [CI] 3.6 -303.4). When active extravasa- The Journal of TRAUMA Injury, Infection, and Critical Care tion on angiography was combined with moderate or large hemoperitoneum, 10 out of 14 (71%) patients failed. One patient had an arteriovenous fistula, and he failed. Those who were embolized with occlusive particles such as gelfoam had a 50% failure rate, whereas those undergoing coil embolization failed 23% of the time. Selective distal embolization failed in 33% of the cases compared with main splenic artery failure rate of 22%. Fourteen patients had evidence of pseudoaneurysms on angiography, of whom four (29%) failed.
Nonoperative management and failure rates as they have changed over the study period are demonstrated in Table 4 . The failure rate for nonoperative management was 18% in the final 18 months, compared with 10% in the prior 36 months. The increase in failures was predominantly in the EMBO group. Of note, the patients going directly to the OR increased from 17% in the first 18 months to 28% in the last 36 months of the study period.
DISCUSSION
Splenic salvage by nonoperative management has become the standard of care in treating splenic injuries in stable patients. Delayed rupture and ongoing bleeding remain the threats of nonoperative splenic trauma management. Therefore, predicting and possibly preventing this has become the most recent focus. A number of centers have reported their management protocols for splenic injuries. Sclafani and colleagues 5 performed arteriography on all patients with splenic injuries and embolized injuries liberally. Davis and colleagues 6 were more selective but still aggressive, obtaining routine early follow-up CT scans and embolizing abnormal arteries. Our protocol for nonoperative management is less aggressive but similar to many in the literature. Patients who are hemodynamically compromised are taken emergently to the OR for exploration. Those who are stable are admitted for nonoperative management and selected for splenic EMBO based on the presence of a blush on CT scan or continued bleeding.
The overall failure rate of nonoperative management during the study period was 14%. The majority of these failures were among the group undergoing EMBO. This is not surprising, as these patients were selected for EMBO based on either radiographic or clinical evidence of active hemorrhage. However, the failure rate among our EMBO patients was 27%, which is much higher than that reported by individual institutional studies and the WTA multicenter trial. 12 Our recognition of a recent increase in these failures prompted this review.
The largest single-center splenic injury series to date is the recent retrospective review of 648 patients by Haan and colleagues. 10 Of their patients, 280 (43%) went directly to the OR. They reported 132 (20%) patients undergoing EMBO, with a failure rate of 10%. Although our EMBO failure rate is higher (27%), our initial operative rate is only 25%. Thus, when nonoperative failures are included, our total operative rate is 36%, compared with their total operative rate of 47%. Obviously, the primary concern is not the splenectomy rate, but patient safety. A secondary concern is resource utilization.
We could not find evidence that any patients were harmed by failed EMBO, although we recognize that it could be difficult to determine that with certainty. There were a number of complications related to EMBO, which in some cases led to the need for splenectomy. There were 3 procedural complications: a femoral artery dissection, a femoral artery arteriovenous fistula, and a splenic artery dissection. The third patient required splenectomy. One EMBO patient developed a splenic abscess requiring splenectomy, which was complicated by portal vein thrombosis. Another patient suffered a deep vein thrombosis requiring anticoagulation. One patient returned 1 month after injury with a symptomatic left pleural effusion requiring drainage. Seven patients experienced thrombocytosis, but none required treatment or had adverse effects.
We do not think we have simply shifted patients from the direct-to-OR group to the EMBO group. In fact, the directto-OR rate increased markedly from the first 18-month period Percent of total cases in parenthesis (%). OR, operating room; NonOp, nonoperative management; EMBO, angioembolization.
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Volume 61 • Number 3(17%) to the later 36 months (28%). While the purpose of this study was not to evaluate the severity of injuries that present to our hospital, the trend of increasing numbers of patients requiring initial operative management suggests a more severely injured population in recent years. This is consistent with a recently published review of our experience over the past decade. 15 Prior studies have suggested that extravasation on CT scan predicts a high risk of failure. 8, 12 Our clinical pathway dictates that if a patient has extravasation on CT scan, they undergo angiography and EMBO. If extravasation was still evident on angiography in this series, there was a 59% chance of failure, compared with only 4% if there was no extravasation seen. This, in fact, was the only variable significantly predictive of failure. Unfortunately, we have no way of predicting which patients with blush on CT scan will have a splenic arteriogram without extravasation. Thus, we cannot necessarily be more selective about sending patients for EMBO. Pseudoaneurysms have also been identified as a risk factor for failure. 6 In the current study, 29% of those with evidence of pseudoaneurysms on angiography ultimately failed EMBO; roughly the same failure rate as those without pseudoaneurysms. A larger study might clarify whether pseudoaneurysms actually represent increased risk of failure. If so, it is possible that the newer-generation multidetector row CT scanners will be able to accurately distinguish pseudoaneurysms from extravasation.
Although the differences were not statistically significant, our data indicate a higher failure rate among older patients: 5 of 23 (22%) of patients age 55 or older failed, whereas 18 of 142 (13%) patients younger than 55 failed. In reviewing the hemodynamics of the EMBO patients, we found that four (10%) of the 41 who underwent EMBO had transient hypotension in the ED. There is little experience with embolizing patients who are transient responders. Hagiwara and colleagues 16 have suggested that EMBO be used routinely in hypotensive patients who transiently respond to fluid administration. While the potential for splenic salvage is enticing, our 75% failure rate (3 of 4) in this group suggests that this course be undertaken with caution. We feel that any hypotension in the ED warrants close monitoring by a surgeon during angiography and low threshold for transfer to the OR.
Embolization techniques varied depending on the interventional radiologist performing the procedure. Two patients had occlusive particles alone and one (50%) failed. The failure rate among the 22 who underwent coil embolization was 23%. When both were used, 7 of 17 patients (41%) failed. This likely represents a population of patients who did not get adequate occlusion with coils alone, requiring attempts of hemostasis with additional particulate embolization. Selective distal embolization failed in 3 out of 9 patients (33%) while main splenic artery embolization failed in 6 out of 27 (22%) patients. An additional five patients underwent both main and selective embolization with two patients failing. Further review of our embolization techniques is currently underway to determine our optimal management. Re-embolization has been discussed by Haan and colleagues. 12 We have not included this strategy in our protocol, as we think failure of one embolization generally warrants splenectomy.
In summary, our EMBO failure rate increased markedly in the most recent 18 months of our study period. While injury severity and embolization techniques may impact success, patient selection appears to be the critical factor. With the realization that angioembolization is not the panacea for splenic bleeding, we anticipate a correction in this trend. We recommend a low threshold to operate if there is any evidence of bleeding in an embolized patient who had extravasation on arteriography, if the patient is older than 55, or if there is a grade III to V injury combined with moderate or large hemoperitoneum. Further study is needed to determine the risks, benefits, and long-term ramifications of splenic EMBO. Do you have a big dog and some little dogs who are there at night who aren't as good as the big dog who is there during the day?
Secondly, the differences in technique are very important. Central embolization may well tend to fail because of persistent hemorrhage, whereas peripheral embolization may fail late because of sepsis and infarction of the spleen.
So, did you track whether these failures were early or late? Whether they were all because of persistent hemorrhage or whether some of them were because of late complications of sepsis in the left upper quadrant?
Dr. Hadley E. Smith: As far as tracking the angiographers, we have not broached that; however, our data is in their hands as well, as they have helped us with the grading, and they are currently looking at their own protocols, because there isn't a set protocol into who gets what.
Some patients received coil embolizations. Some received particles. Therefore, in some patients it seemed they received coils, then particles, then more coils, and then more particles. It's hard to tell if this aggressive approach was necessary because of technical placement or because of severity of injury. This is currently under study in their department.
As far as our complications and failures, the majority of our failures happened fairly early, within the first 2 or 3 days. We did have one patient who had a failure of a splenic abscess, and that patient returned to the OR at about 6 days.
Currently, I don't know if that patient had a main or a distal embolization.
Dr. Donald D. Trunkey (Portland, Oregon): I am disappointed in your conclusions. Based on your data and Dr. Peitzman's most recent paper, I think the answer is, unequivocally, that we have gone too far.
However, I am curious, regarding a fundamental question that isn't being answered: If you embolize, either the splenic artery or peripherally, is there function afterwards? If we leave it up to the radiologists, we'll never answer that question.
We should be studying spleen function after embolization to see if T-cell function is maintained, and does it really work in preventing the late thrombo-embolism and myocardial infarction?
I would encourage you to do this on those patients that "had successful embolization", because I have real doubts.
Dr. Hadley E. Smith: I agree. In reviewing the charts, we were able to see complications, like we had thrombocytosis in seven patients.
We gave them aspirin and there were no complications as a result. However, do we follow our trauma patients up any significant distance? Can we find them after a certain amount of time?
It's very difficult and a daunting task, but I agree. We can get them through the beginning and stop their hemorrhage, but it's hard to know exactly what benefit we're giving them long term.
